Retinoic acid receptor responder protein 1

BE0000653ProteinHumansRARRES1

Inhibitor of the cytoplasmic carboxypeptidase AGBL2, may regulate the alpha-tubulin tyrosination cycle. It is acted on by 1 drug in DrugBank.

Gene name
RARRES1
UniProtKB entry
P49788Swiss-Prot
Cellular location
Membrane
Residues / weight
294 residues · 33,285 Da
Also known as
PEIG1 · PERG-1 · Phorbol ester-induced gene 1 protein · RAR-responsive protein TIG1 · Tazarotene-induced gene 1 protein

Resolves to

Protein
UniProtP49788UniProt nameTIG1_HUMAN
Gene
HGNCHGNC:9867NCBI Gene5918GenBank942585GeneCardsRARRES1
Pharmacology
KEGGhsa:5918
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
1GO termFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Retinoic acid receptor responder protein 1, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In